Radio and PodcastLive Radio & PodcastsScience & Medicine
Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology
Research fellow, Adrian Chen, discusses a multicenter study evaluating myocardial PD‑L1 expression as a prognostic biomarker in immune checkpoint inhibitor–associated myocarditis. The conversation highlights how elevated...
About This Episode
Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology is an episode from JACC: Clinical Electrophysiology by American College of Cardiology. Research fellow,...
Podcast
This episode belongs to JACC: Clinical Electrophysiology.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Apr 21, 2026, 02:06 long, audio available.
Related Episodes
Continue listening to more episodes from JACC: Clinical Electrophysiology.
Questions About This Episode
What is Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology about?
Research fellow, Adrian Chen, discusses a multicenter study evaluating myocardial PD‑L1 expression as a prognostic biomarker in immune checkpoint inhibitor–associated myocarditis. The conversation highlights how elevated myocardial PD‑L1 identifies patients at markedly higher risk for early adverse cardiac events and explores its potential role in improving risk stratification and guiding earlier, more aggressive therapy in this high‑risk population.
Where can I listen to Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology?
You can listen to Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology from?
Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology is an episode from JACC: Clinical Electrophysiology by American College of Cardiology.
How long is this episode?
This episode is 02:06 long.
When was this episode published?
This episode was published on Apr 21, 2026.
Can I save Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from JACC: Clinical Electrophysiology?
Yes. This page shows related episodes from JACC: Clinical Electrophysiology when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology?
You can listen to Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Myocardial Expression of PD-L1 as a Marker of Poor Prognosis in Immune Checkpoint Inhibitor–Associated Myocarditis JACC: CardioOncology is from JACC: Clinical Electrophysiology by American College of Cardiology.
What are the episode details?
Published Apr 21, 2026 and 02:06 long